Olivier Chinot
Aix-Marseille Université
H-index: 74
Europe-France
Top articles of Olivier Chinot
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Repeated blood–brain barrier opening with a nine-emitter implantable ultrasound device in combination with carboplatin in recurrent glioblastoma: a phase I/II clinical trial | Nature Communications | Alexandre Carpentier Roger Stupp Adam M Sonabend Henry Dufour Olivier Chinot | 2024/2/23 |
Prognostic value of Beta 2-Microglobulinin in cerebrospinal fluid in primary central nervous system lymphoma. | Journal of the Neurological Sciences | Alexandre Bertucci Céline Boucard Vincent Harlay Romain Appay Gregorio Petrirena | 2024/2/15 |
Zotiraciclib (TG02) for newly diagnosed glioblastoma in the elderly or for recurrent glioblastoma: The EORTC 1608 STEAM trial | European Journal of Cancer | Emilie Le Rhun Thierry Gorlia Jörg Felsberg Joost Jongen Claude-Alain Maurage | 2024/2/1 |
Peptide radionuclide radiation therapy with Lutathera in multirecurrent nonanaplastic meningiomas: antitumoral activity study by growth rate analysis | Journal of Neuro-Oncology | Thomas Graillon Betty Salgues Tatiana Horowitz Laetitia Padovani Romain Appay | 2024/3/7 |
Primary central nervous system lymphoma with initial spinal cord involvement (PCNSL-SC) is a rare entity: 4 case reports and review of literature | Revue Neurologique | V Harlay C Campello C Bequet G Petrirena M Barrie | 2024/3/1 |
Long-term survival with IDH wildtype glioblastoma: first results from the ETERNITY Brain Tumor Funders’ Collaborative Consortium (EORTC 1419) | European Journal of Cancer | Caroline Hertler Jörg Felsberg Dorothee Gramatzki Emilie Le Rhun Jennifer Clarke | 2023/8/1 |
CTNI-34. ZOTIRACICLIB (TG02) FOR NEWLY DIAGNOSED GLIOBLASTOMA IN THE ELDERLY OR FOR RECURRENT GLIOBLASTOMA: FINAL RESULTS OF THE EORTC 1608 STEAM TRIAL | Neuro-Oncology | Emilie Le Rhun Thierry Gorlia Jörg Felsberg Julia Furtner Joost Jongen | 2023/11/1 |
Innovative treatments for meningiomas | T Graillon E Tabouret B Salgues T Horowitz L Padovani | 2023/3/21 | |
Phase III study of the European Organisation for Research and Treatment of Cancer Quality of Life cancer survivorship core questionnaire | Journal of Cancer Survivorship | Marieke van Leeuwen Jacobien M Kieffer Teresa E Young Maria Antonietta Annunziata Volker Arndt | 2023/8 |
546P Early urinary potassium level is predictive of delayed methotrexate (MTX) elimination in patients with primary central nervous system lymphoma (PCNSL) | Annals of Oncology | A Bertucci V Harlay C Boucard G Petrirena C Campello | 2023/10/1 |
Contribution of nuclear medicine to the diagnosis and management of primary brain tumours | T Horowitz E Tabouret T Graillon B Salgues O Chinot | 2023/3/16 | |
Optic Nerve Sheath Meningiomas: Solving Diagnostic Challenges with 68Ga-DOTATOC PET/CT | Diagnostics | Tatiana Horowitz Betty Salgues Laetitia Padovani Kaissar Farah Henry Dufour | 2023/7/7 |
KS02. 5. A OVERALL SURVIVAL ASSOCIATED WITH FIRST-LINE PCV OR TEMOZOLOMIDE IN COMBINATION WITH RADIOTHERAPY IN PATIENTS WITH IDH-MUTANT, 1P/19Q CODELETED, GRADE 3 … | Neuro-Oncology | SEO Kacimi C Dehais C Carpentier O Chinot C Bronnimann | 2023/9/1 |
Incidence and characteristics of pseudoprogression in IDH-mutant high-grade gliomas: a POLA network study | Neuro-oncology | Antoine Seyve Caroline Dehais Olivier Chinot Apolline Djelad Elisabeth Cohen-Moyal | 2023/3/1 |
Final analysis of the phase IB part of the LOC-R01 trial, a non-comparative randomized phase IB/II study of escalating doses of lenalidomide and ibrutinib in association with R … | Marion Alcantara Marion Chevrier Fabrice Jardin Anna Schmitt Caroline Houillier | 2023/6/1 | |
Radio-chemotherapy feasibility for biopsy-only unresectable IDH wild-type glioblastomas (BO-GBM) | Neuro-Oncology Practice | Vincent Harlay Romain Appay Céline Bequet Gregorio Petrirena Chantal Campello | 2023/12/1 |
Primary central nervous system lymphoma (PCNSL) in older patients | Alexandre Bertucci Vincent Harlay Olivier Chinot Emeline Tabouret | 2023/9/1 | |
Molecular and clinical diversity in primary central nervous system lymphoma | Annals of Oncology | I Hernández-Verdin E Kirasic K Wienand K Mokhtari S Eimer | 2023/2/1 |
Le méningiome est une tumeur bénigne… sauf quand il est malin | Revue Neurologique | Vincent Harlay Gregorio Petrirena Thomas Graillon Laeticia Padovani Eric Guedj | 2023/4/1 |
Combination drug screen targeting glioblastoma core vulnerabilities reveals pharmacological synergisms | EBioMedicine | Jérémy Ariey-Bonnet Raphael Berges Marie-Pierre Montero Baptiste Mouysset Patricia Piris | 2023/9/1 |
